Academia
Researchers from the University of Birmingham, UK, announced today that they have developed a nasal spray that can potentially provide protection against COVID-19. Additionally, it is formulated using materials that have already been cleared for use in humans.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
AstraZeneca and the University of Oxford published Phase II clinical trial results for their COVID-19 vaccine in The Lancet. The data shows the vaccine is safe and offers a similar immune response in all adults.
Researchers at Weill Cornell Medicine identified a specific and unique kind of immune cell activity in the lungs of COVID-19 patients.
The United States continues to headline an annual list of influential science researchers, but that lead is dipping as other global scientists gain recognition from their peers for the work they are conducting.
A group of Researchers in St. Louis published the results of a clinical trial evaluating antidepressant fluvoxamine, for early treatment for COVID-19.
Researchers from Penn Medicine have developed a new targeted approach that modifies viral vectors and inhibits toxicities in the sensory neurons of dorsal root ganglia that commonly occur following the use of gene therapy for neurological diseases.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers from the Thomas Jefferson University have designed an antigen-specific therapy for the autoimmune disease multiple sclerosis (MS) using oligodendrocyte-derived extracellular vesicles.
Harvard immunology experts comment on studies regarding antibodies in COVID-19 patients diminishing over time.
PRESS RELEASES